Hideki Nakakuma

2.1k total citations
74 papers, 1.5k citations indexed

About

Hideki Nakakuma is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Hideki Nakakuma has authored 74 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 19 papers in Hematology and 17 papers in Molecular Biology. Recurrent topics in Hideki Nakakuma's work include Complement system in diseases (30 papers), Adenosine and Purinergic Signaling (14 papers) and Immune Cell Function and Interaction (13 papers). Hideki Nakakuma is often cited by papers focused on Complement system in diseases (30 papers), Adenosine and Purinergic Signaling (14 papers) and Immune Cell Function and Interaction (13 papers). Hideki Nakakuma collaborates with scholars based in Japan, United States and Germany. Hideki Nakakuma's co-authors include Tatsuya Kawaguchi, Shoichi Nagakura, Kentaro Horikawa, Tadashi Kagimoto, Kiyoshi Takatsuki, Taroh Kinoshita, Michael Andreeff, Kensuke Kojima, Nobuyoshi Hanaoka and Norihiro Iwamoto and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Hideki Nakakuma

74 papers receiving 1.5k citations

Peers

Countries citing papers authored by Hideki Nakakuma

Since Specialization

Citations

This map shows the geographic impact of Hideki Nakakuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Nakakuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Nakakuma more than expected).

Fields of papers citing papers by Hideki Nakakuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Nakakuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Nakakuma. The network helps show where Hideki Nakakuma may publish in the future.

Co-authorship network of co-authors of Hideki Nakakuma

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Nakakuma. A scholar is included among the top collaborators of Hideki Nakakuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Nakakuma. Hideki Nakakuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome 2017 ·Leukemia Research ·(unknown), Ken‐Ichi Imadome, Shinobu Tamura, (unknown), Shogo Murata, Yusuke Yamashita, (unknown), (unknown), (unknown), (unknown), Hideki Nakakuma, Nobuyoshi Hanaoka, Yasushi Isobe, Kouichi Ohshima, Takashi Sonoki	1
2	B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia 2015 ·Hematology Reports ·Nobuyoshi Hanaoka, Shogo Murata, (unknown), Aiko Shimokado, (unknown), (unknown), Kazuo Hatanaka, (unknown), (unknown), Takashi Sonoki, Yasuteru Muragaki, Hideki Nakakuma	3
3	Acute Leukemia Showing t(8;22)(p11;q11), Myelodysplasia, CD13/CD33/CD19 Expression and Immunoglobulin Heavy Chain Gene Rearrangement 2013 ·Acta Haematologica ·(unknown), Takashi Sonoki, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kazuo Hatanaka, Nobuyoshi Hanaoka, Hideki Nakakuma	11
4	Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial 2013 ·International Journal of Hematology ·Yuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima, Shinichiro Okamoto, Kiyoshi Ando, Haruhiko Ninomiya, Tatsuya Kawaguchi, Shinji Nakao, Hideki Nakakuma, J Nishimura, Taroh Kinoshita, Camille L. Bedrosian, Keiya Ozawa, Mitsuhiro Omine	29
5	Eμ/miR-125b transgenic mice develop lethal B-cell malignancies 2011 ·Leukemia ·Yutaka Enomoto, Jiro Kitaura, Kinta Hatakeyama, (unknown), Takashi Akasaka, Naoko Kato, (unknown), Koutarou Nishimura, Mariko Takahashi, Masafumi Taniwaki, Claudia Haferlach, Reiner Siebert, Martin J.S. Dyer, Norio Asou, Hiroyuki Aburatani, Hideki Nakakuma, Toshio Kitamura, Takashi Sonoki	71
6	Cyclin‐dependent kinase 1 inhibitor RO‐3306 enhances p53‐mediated Bax activation and mitochondrial apoptosis in AML 2009 ·Cancer Science ·Kensuke Kojima, (unknown), Masato Shikami, Michael Andreeff, Hideki Nakakuma	38
7	Successful treatment with liposomal doxorubicin for widespread Kaposi’s sarcoma and human herpesvirus-8 related severe hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome 2009 ·International Journal of Hematology ·Shima Uneda, Shogo Murata, Takashi Sonoki, Hiroshi Matsuoka, Hideki Nakakuma	7
8	NKG2D‐mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes 2009 ·British Journal of Haematology ·Nobuyoshi Hanaoka, Hideki Nakakuma, Kentaro Horikawa, Shoichi Nagakura, (unknown), (unknown), Kensuke Kojima, Yuji Yonemura, Tatsuya Kawaguchi	16
9	Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis 2009 ·Leukemia ·Kensuke Kojima, Marina Konopleva, Twee Tsao, Michael Andreeff, Hiroyuki Ishida, Yukimasa Shiotsu, Lin Jin, Yoko Tabe, Hideki Nakakuma	25
10	Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27 2008 ·International Journal of Hematology ·Shima Uneda, (unknown), Takashi Sonoki, Kazuhiro Nishida, Yasushi Nakamura, (unknown), Nobuyoshi Hanaoka, Hiroshi Matsuoka, Masafumi Taniwaki, Hideki Nakakuma	1
11	Paroxysmal Nocturnal Hemoglobinuria 2005 ·International Journal of Hematology ·Mitsuhiro Omine, Taroh Kinoshita, Hideki Nakakuma, Jaroslaw P. Maciejewski, Charles J. Parker, Gèrard Socié	16
12	Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan 2004 ·Medicine ·Jun‐ichi Nishimura, Yuzuru Kanakura, Russell E. Ware, Tsutomu Shichishima, Hideki Nakakuma, Haruhiko Ninomiya, Carlos M. DeCastro, Sharon Hall, Akihisa Kanamaru, Keith M. Sullivan, Hideaki Mizoguchi, Mitsuhiro Omine, Taroh Kinoshita, Wendell F. Rosse	186
13	PIG-W Is Critical for Inositol Acylation but Not for Flipping of Glycosylphosphatidylinositol-Anchor 2003 ·Molecular Biology of the Cell ·Yoshiko Murakami, (unknown), Yeongjin Hong, Ji Young Kang, (unknown), Hideki Nakakuma, Yusuke Maeda, Taroh Kinoshita	82
14	Pathogenesis of Selective Expansion of PNH Clones 2003 ·International Journal of Hematology ·Hideki Nakakuma, Tatsuya Kawaguchi	11
15	Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) 1996 ·American Journal of Hematology ·Hideki Nakakuma	19
16	Ganglioside-induced inhibition of in vivo immune response in mice 1992 ·Life Sciences ·(unknown), Hideki Nakakuma, Hiroshi Shionoya, Tatsuya Kawaguchi, Kiyomi Yamatsu, Kiyoshi Takatsuki	15
17	Concanavalin A-stimulated expression of gangliosides with GalNAc?1-4(NeuAc?2-3)Gal? structure in murine thymocytes 1991 ·Glycoconjugate Journal ·Kentaro Horikawa, (unknown), Masao Iwamori, Hideki Nakakuma, Kiyoshi Takatsuki, (unknown)	14
18	Inhibition of Human Immunodeficiency Virus Infection of Human Lymphocytes by Gangliosides 1989 ·Japanese Journal of Cancer Research ·Hideki Nakakuma, Tatsuya Kawaguchi, Atsushi Koito, Toshio Hattori, Tadashi Kagimoto, Kiyoshi Takatsuki	10
19	Effect of Microinjected Catalytic Fragment of Protein Kinase C on Morphological Change in Swiss 3T3 Cells 1989 ·PubMed ·Hideki Nakakuma, Mark C. Willingham, Peter M. Blumberg	4
20	Activation of human neutrophil NADPH-oxidase in vitro by the catalytic fragment of protein kinase-C 1989 ·Biochemical and Biophysical Research Communications ·Alfred I. Tauber, Jane A. Cox, John T. Curnutte, (unknown), Hideki Nakakuma, Barbour S. Warren, (unknown), Peter M. Blumberg	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact